19809

0

MAITREYA

img img img img
No Data Available

MAITREYA MEDICARE LIMITED Share Price Update

As of the latest trading session, MAITREYA MEDICARE LIMITED is trading at ₹163.8, down by ₹-1.00 or -0.60% from its previous close. The stock has moved between ₹160.00 and ₹164.00 today. Over the past year, the stock has delivered a return of -42.57%. In the last month, it has returned -9.30%.

MAITREYA MEDICARE LIMITED performance

Today’s low Today’s high
₹ 160.00 ₹ 164.00
₹ 163.80
52 week low 52 week high
₹ 152.70 ₹ 298.80
₹ 163.80
Open Price ₹ 164.00
Prev. Close ₹ 164.80
Volume (Shares) 2400.00
Total traded value ₹ 3.93
Upper Circuit ₹ 197.75
Lower Circuit ₹ 131.85
info

Investment Returns

Over 1 Month -9.30% Over 3 Months -12.84% Over 6 Months -33.81% Over 1 Year -42.57%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MAITREYA MEDICARE LIMITED fundamentals


  • Market cap (Cr) 111.00
  • P/E Ratio (TTM) 58.50
  • Beta -0.10
  • Book Value / share 39.49
  • Return on equity 7.36%
  • EPS (TTM) 2.78
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -0.89
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

MAITREYA MEDICARE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2024 (Values in Cr)
Revenue 10.60
Operating Expense 11.96
Net Profit -0.89
Net Profit Margin (%) -8.39
Earnings Per Share (EPS) -1.34
EBITDA -0.63
Effective Tax Rate (%) 24.57
Particulars DEC 2023 (Values in Cr)
Revenue 11.65
Operating Expense 9.53
Net Profit 1.60
Net Profit Margin (%) 13.73
Earnings Per Share (EPS) 2.88
EBITDA 2.55
Effective Tax Rate (%) 24.64
Particulars SEP 2023 (Values in Cr)
Revenue 13.53
Operating Expense 11.21
Net Profit 1.84
Net Profit Margin (%) 13.59
Earnings Per Share (EPS) 3.53
EBITDA 2.81
Effective Tax Rate (%) 22.36
Particulars JUN 2023 (Values in Cr)
Revenue 10.75
Operating Expense 0.00
Net Profit 0.61
Net Profit Margin (%) 5.67
Earnings Per Share (EPS) 1.24
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 10.50
Operating Expense 8.22
Net Profit 1.79
Net Profit Margin (%) 17.04
Earnings Per Share (EPS) 2.69
EBITDA 3.07
Effective Tax Rate (%) 31.15
Particulars MAR 2025 (Values in Cr)
Revenue 44.41
Operating Expense 41.63
Net Profit 1.90
Net Profit Margin (%) 4.27
Earnings Per Share (EPS) 2.80
EBITDA 5.32
Effective Tax Rate (%) 40.99
Particulars MAR 2024 (Values in Cr)
Revenue 46.53
Operating Expense 42.36
Net Profit 3.17
Net Profit Margin (%) 6.81
Earnings Per Share (EPS) 6.65
EBITDA 6.39
Effective Tax Rate (%) 27.56
Particulars MAR 2023 (Values in Cr)
Revenue 38.48
Operating Expense 33.17
Net Profit 3.30
Net Profit Margin (%) 8.57
Earnings Per Share (EPS) 6.65
EBITDA 7.68
Effective Tax Rate (%) 28.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 39.43
ROE % 7.25
ROCE % 10.95
Total Debt to Total Equity 0.18
EBITDA Margin 11.68
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.67
ROE % 15.53
ROCE % 17.87
Total Debt to Total Equity 0.26
EBITDA Margin 13.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.68
ROE % 58.61
ROCE % 34.66
Total Debt to Total Equity 0.55
EBITDA Margin 19.78
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4711.12
ROE % 19.84
ROCE % 13.47
Total Debt to Total Equity 0.90
EBITDA Margin 7.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3862.16
ROE % 103.37
ROCE % 36.13
Total Debt to Total Equity 1.03
EBITDA Margin 13.57
Particulars MAR 2025 (Values in Cr)
Book Value / Share 39.49
ROE % 7.36
ROCE % 11.36
Total Debt to Total Equity 0.12
EBITDA Margin 11.98
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.69
ROE % 16.71
ROCE % 18.73
Total Debt to Total Equity 0.22
EBITDA Margin 13.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.71
ROE % 54.52
ROCE % 33.53
Total Debt to Total Equity 0.54
EBITDA Margin 19.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5485.40
ROE % 21.70
ROCE % 11.95
Total Debt to Total Equity 0.84
EBITDA Margin 6.99
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4372.60
ROE % 203.70
ROCE % 44.04
Total Debt to Total Equity 1.29
EBITDA Margin 13.77
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.91
Total Assets 47.99
Total Liabilities 47.99
Total Equity 32.85
Share Outstanding 0
Price to Book Ratio 7.74
Return on Assets (%) 3.90
Return on Capital (%) 4.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.55
Total Assets 43.86
Total Liabilities 43.86
Total Equity 30.35
Share Outstanding 0
Price to Book Ratio 3.24
Return on Assets (%) 6.77
Return on Capital (%) 8.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.93
Total Assets 28.91
Total Liabilities 28.91
Total Equity 15.54
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.70
Return on Capital (%) 19.88
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 24.48
Total Liabilities 24.48
Total Equity 10.87
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.64
Return on Capital (%) 6.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.90
Total Assets 25.27
Total Liabilities 25.27
Total Equity 9.59
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 16.79
Return on Capital (%) 22.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.90
Total Assets 44.41
Total Liabilities 44.41
Total Equity 32.07
Share Outstanding 0
Price to Book Ratio 7.74
Return on Assets (%) 4.27
Return on Capital (%) 5.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.66
Total Assets 40.51
Total Liabilities 40.51
Total Equity 30.25
Share Outstanding 0
Price to Book Ratio 3.24
Return on Assets (%) 7.83
Return on Capital (%) 9.25
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.48
Total Assets 27.74
Total Liabilities 27.74
Total Equity 14.51
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 15.08
Return on Capital (%) 20.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 22.83
Total Liabilities 22.83
Total Equity 10.36
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.66
Return on Capital (%) 5.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 25.89
Total Liabilities 25.89
Total Equity 9.42
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 17.02
Return on Capital (%) 23.69
Particulars MAR 2025 (Values in Cr)
Net Income 3.21
Cash from Operations 6.52
Cash from Investing -7.37
Cash from Financing 3.67
Net change in Cash 1.35
Free Cash Flow 8.90
Particulars MAR 2024 (Values in Cr)
Net Income 4.15
Cash from Operations -0.73
Cash from Investing -5.43
Cash from Financing 12.20
Net change in Cash 4.26
Free Cash Flow 0.88
Particulars MAR 2023 (Values in Cr)
Net Income 5.95
Cash from Operations 2.90
Cash from Investing 0.36
Cash from Financing -1.58
Net change in Cash 1.36
Free Cash Flow 2.93
Particulars MAR 2022 (Values in Cr)
Net Income 1.59
Cash from Operations 1.80
Cash from Investing -0.01
Cash from Financing -1.86
Net change in Cash -1.80
Free Cash Flow 2.70
Particulars MAR 2021 (Values in Cr)
Net Income 5.77
Cash from Operations 5.60
Cash from Investing -5.06
Cash from Financing 2.16
Net change in Cash 1.54
Free Cash Flow 11.23
Particulars MAR 2025 (Values in Cr)
Net Income 3.22
Cash from Operations 6.48
Cash from Investing -7.20
Cash from Financing -1.57
Net change in Cash -3.75
Free Cash Flow 8.85
Particulars MAR 2024 (Values in Cr)
Net Income 4.38
Cash from Operations 1.51
Cash from Investing -5.56
Cash from Financing 10.00
Net change in Cash 4.17
Free Cash Flow 2.19
Particulars MAR 2023 (Values in Cr)
Net Income 5.87
Cash from Operations 2.72
Cash from Investing 0.35
Cash from Financing -1.33
Net change in Cash 1.43
Free Cash Flow 2.75
Particulars MAR 2022 (Values in Cr)
Net Income 1.41
Cash from Operations 2.00
Cash from Investing 0.16
Cash from Financing -2.61
Net change in Cash -1.67
Free Cash Flow 2.90
Particulars MAR 2021 (Values in Cr)
Net Income 5.97
Cash from Operations 5.12
Cash from Investing -5.62
Cash from Financing 1.51
Net change in Cash 0.78
Free Cash Flow 10.60
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8177.95 60.11 12.41 117586.37 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.98 24.43 2.94 101.17 40.75 77.00
SHREE PACETRONIX LTD. 142.40 16.99 2.99 53.40 66.10 283.15
TRANSGENE BIOTEK LTD. 3.15 0.00 2.59 23.87 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8177.95 78.33 11.80 117586.37 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.69 0.00 -9.41 28.90 30.30 57.48
KOVAI MEDICAL CENTER & HO 5357.25 23.97 4.44 5860.83 5010.00 6725.00

MAITREYA MEDICARE LIMITED shareholding pattern

Holding
26.88%
73.11%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MAITREYA MEDICARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
163.80 -0.60 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 166.40
  • 26 Days 173.40
  • 10 Days 168.90
  • 50 Days 180.50
  • 12 Days 169.60
  • 100 Days 195.70
  • 20 Days 171.90
  • 200 Days 216.40
164.78 PIVOT
First Support 161.67 First Resistance 167.92 Second Support 158.53 Second Resistance 171.03 Third Support 155.42 Third Resistance 174.17
RSI 40.73 ADX 24.05 MACD -3.78 Williams % R -87.75 Commodity Channel Index (CCI) -142.87
Date 2026-05-29 Week 2080.00 Same Day 1600.00 Month 1844.00
1 Year -0.10 3 Year 0.35
Over 1 Month
-9.30% down
Over 1 Year
-42.57% down
Over 3 Months
-12.84% down
Over 3 Years
1.97% down
Over 6 Months
-33.81% down
Over 5 Years
0.00% down

MAITREYA MEDICARE LIMITED Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Maitreya Medicare Ltd?

Answer Field

Maitreya Medicare Ltd share price is for NSE ₹ 163.80 & for BSE ₹ 0.00 as on May 29 2026 03:22 PM.

What is the Market Cap of Maitreya Medicare Ltd Share?

Answer Field

The market cap of Maitreya Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 29 2026 03:22 PM.

What is the 52 Week High and Low of Maitreya Medicare Ltd?

Answer Field

The 52 Week High and Low of Maitreya Medicare Ltd for NSE is ₹ 298.80 and ₹ 152.70 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Maitreya Medicare Ltd?

Answer Field

The 1 year returns on the stock has been -42.57%.

What is the P/E Ratio of Maitreya Medicare Ltd Share?

Answer Field

As on May 29 2026 03:22 PM the price-to-earnings (PE) ratio for Maitreya Medicare Ltd share is 58.50.

What is the PB ratio of Maitreya Medicare Ltd Share?

Answer Field

As on May 29 2026 03:22 PM, the price-to-book (PB) ratio for Maitreya Medicare Ltd share is 39.49.

How to Buy Maitreya Medicare Ltd Share?

Answer Field

You can trade in Maitreya Medicare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Maitreya Medicare Ltd Share on Bajaj Broking App?

Answer Field

To buy Maitreya Medicare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Maitreya Medicare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|